KR850001151A - r-알레닐-r-아미노부티르산의 제조방법 - Google Patents

r-알레닐-r-아미노부티르산의 제조방법 Download PDF

Info

Publication number
KR850001151A
KR850001151A KR1019840003936A KR840003936A KR850001151A KR 850001151 A KR850001151 A KR 850001151A KR 1019840003936 A KR1019840003936 A KR 1019840003936A KR 840003936 A KR840003936 A KR 840003936A KR 850001151 A KR850001151 A KR 850001151A
Authority
KR
South Korea
Prior art keywords
acid
alkyl
compound
pharmaceutically acceptable
amino
Prior art date
Application number
KR1019840003936A
Other languages
English (en)
Inventor
란즈(외 1) 아렉산더
Original Assignee
원본미기재
신텍스(유ㆍ에스ㆍ에시) 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 신텍스(유ㆍ에스ㆍ에시) 인코포레이티드 filed Critical 원본미기재
Publication of KR850001151A publication Critical patent/KR850001151A/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/2672-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4042,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide

Abstract

내용 없음

Description

r-알레닐-r-아미노부티르산의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (18)

  1. 일반식(IA) 화합물을 가수분해하거나; R5가 하이드록시인 일반식(I) 화합물의 유리산을 에스테르화하거나; R5가 하이드록시인 일반식(I) 화합물을 아미드화하거나; R4가 수소인 일반식(I) 화합물을 아미드화하거나; 일반식(I) 화합물의 유리염기를 산과 반응시켜 약학적으로 허용되는 산부가염으로 전환시키거나; 일반식(I) 화합물의 유리산을 염기와 반응시켜 약학적으로 허용되는 산성염으로 전환시키거나; 산성염을 산과 반응시켜 상응하는 유리산으로 전환시키거나; 에스테르를 산과 반응시켜 유리산으로, 또는 염기와 반응시켜 상응하는 약학적으로 허용되는 염으로 전환시키거나; 아미드를 염기와 반응시켜 아민으로, 또는 산과 반응시켜 산부가염으로 전환시킴을 특징으로 하여 일반식(I) 화합물 및 그의 약학적으로 허용되는 염을 제조하는 방법.
    상기 식에서,
    R1은 수소, 할로, C1내지 C4알킬, C7내지 C9알킬페닐 또는 치환된 페닐 또는 C7내지 C9알킬페닐(여기에서 치환체는 할로, C1내지 C4알킬, C1내지 C4알콕시, C1내지 C4티오알킬 또는 C1내지 C4아미노알킬이다), 또는 C1내지 C4설포닐- 또는 설포실알킬, 설포닐- 또는 설폭실아릴, 또는 C1내지 C4설포닐- 또는 설폭실 할로알킬이고;
    R2및 R3은 독립적으로 수소, 할로, C1내지 C4알킬, C7내지 C9알킬페닐 또는 치환된 페닐 또는 C7내지 C9알킬페닐 (여기에서 치환체는 할로, C1내지 C4알킬 C1내지 C4알콕시,C1내지 C4디오알킬,또는 C1내지 C4아미노알킬이다)이고:
    R4는 수소, 알킬부분이 C1내지 C22알킬카보닐, 알콕시부분이 C1내지 C22인 알콕시카보닐 또는 다음 일반식(II)의 그룹이고,
    (여기에서, R6은 수소, C1내지 C4알킬, 벤질 또는 p-하이드록시벤질이다);
    R5는 하이드록실, C1내지 C22알콕시, C1내지 C22알킬아미노 또는 다음 일반식(III)의 그룹이며,
    (여기에서, R7은 수소, C1내지 C4알킬, 벤질 또는 p-하이드록시벤질이다);
    A는 -CH=CH- 또는 일반식(IV)의 그룹이다;
    [여기에서, R8, R8' 및 R8"은 독립적으로 수소, C1내지 C4알킬, 페닐 또는 치환된 페닐(여기에서 치환체는 할로, 또는 C1내지 C4알콕시이다)이며, n은 0 또는 1의 정수이다.]
  2. 제1항에 있어서, R1, R2및 R3가 독립적으로 수소 또는 C1내지 C4알킬이고, R5가 하이드록실 또는 C1내지 C22아실기이며 A는 일반식(IV)의 그룹인 화합물을 제조하는 방법.
    상기 식에서, R8, R8' 및 R8"은 독립적으로 수소, C1내지 C4알킬, 페닐 또는 치환된 페닐(여기에서 치환체는 할로, 또는 C1내지 C4알콕시이다)이며; n은 0 또는 1의 정수이다.
  3. 제2항에 있어서, R1, R2및 R3가 수소인 화합물을 제조하는 방법.
  4. 제3항에 있어서, 4-아미노-5,6-헵타디에노산 또는 그의 약학적으로 허용되는 염을 제조하는 방법.
  5. 제3항에 있어서, 옥틸 4-아미노-5,6-헵타디에노에이트파라-톨루엔 설폰산을 제조하는 방법.
  6. 제3항에 있어서, 에틸 4-아미노-5,6-헵타디에노에이트파라-톨루엔 설폰산 또는 그의 염산염을 제조하는 방법.
  7. 제2항에 있어서, R1, R2및 R3가 독립적으로 수소 또는 메틸인 화합물을 제조하는 방법.
  8. 제7항에 있어서, 4-아미노-5-메틸-5,6-헵타디에노산 또는 그의 약학적으로 허용되는 염을 제조하는 방법.
  9. 제7항에 있어서, 4-아미노-7-메틸-5,6-헵타디에노산 또는 그의 약학적으로 허용되는 염을 제조하는 방법.
  10. 제7항에 있어서, 4-아미노-5,6-옥타디에노산 또는 그의 약학적으로 허용되는 염을 제조하는 방법.
  11. 제7항에 있어서, 옥틸 4-아미노-5-메틸-5,6-헵타디에노산 또는 그의 파라-톨루엔-설폰산염을 제조하는 방법.
  12. 제3항에 있어서, 4-N-3급-부틸옥시카보닐-5,6-헵타디에노산을 제조하는 방법.
  13. 제1항에 있어서, R1또는 R2가 독립적으로 수소 또는 할로이며, R3이 수소이고 R5가 하이드록실 또는 C1내지 C22아실기이고, A는 일반식(IV)의 그룹인 화합물을 제조하는 방법.
    상기 식에서, R8R8' 및 R8"은 독립적으로 수소, C1내지 C4알킬, 페닐 또는 치환된 페닐(여기에서 치환체는 할로, 또는 C1내지 C4알콕시이다)이며; n은 0 또는 1의 정수이다.
  14. 제13항에 있어서, 4-아미노-7-클로로-5,6-헵타디에노산 및 그의 약학적으로 허용되는 염을 제조하는 방법.
  15. 제13항에 있어서, 4-아미노-7-브로모-5,6-헵타디에노산 및 그의 약학적으로 허용되는 염을 제조하는 방법.
  16. 제1항에 있어서, R1또는 R2가 독립적으로 수소 또는 할로이며, R3이 C1내지 C4알킬이며, R5가 하이드록실 또는 C1내지 C22아실기이고, A는 일반식(IV)의 그룹인 화합물을 제조하는 방법.
    상기 식에서, R8, R8' 및 R8"은 독립적으로 수소, C1내지 C4알킬, 페닐 또는 치환된 페닐(여기에서 치환체는 할로, 또는 C1내지 C4알콕시이다)이며; n은 0 또는 1의 정수이다.
  17. 제16항에 있어서, 4-아미노-7-클로로-5-메틸-5,6-헵타디에노산 및 그의 약학적으로 허용되는 염을 제조하는 방법.
  18. 제1항에 있어서, R1, R2, R3및 R4가 모두 수소이고, R5가 하이드록실이며 A는 -CH=CH-인 화합물, 즉 4-아미노-2,5,6-헵타트리에노산 및 그의 약학적으로 허용되는 염을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840003936A 1983-07-07 1984-07-06 r-알레닐-r-아미노부티르산의 제조방법 KR850001151A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51169183A 1983-07-07 1983-07-07
US511691 1983-07-07

Publications (1)

Publication Number Publication Date
KR850001151A true KR850001151A (ko) 1985-03-16

Family

ID=24036025

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840003936A KR850001151A (ko) 1983-07-07 1984-07-06 r-알레닐-r-아미노부티르산의 제조방법

Country Status (14)

Country Link
EP (1) EP0134481B1 (ko)
JP (1) JPS6036448A (ko)
KR (1) KR850001151A (ko)
AT (1) ATE31407T1 (ko)
AU (1) AU566709B2 (ko)
CA (1) CA1252477A (ko)
DE (1) DE3468103D1 (ko)
DK (1) DK335784A (ko)
ES (2) ES8605468A1 (ko)
FI (1) FI842723A (ko)
HU (1) HU198902B (ko)
NO (1) NO842759L (ko)
NZ (1) NZ208805A (ko)
ZA (1) ZA845237B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208345A (en) * 1990-12-17 1993-05-04 Merrell Dow Pharmaceuticals Inc. Process for the production of (S)-vinyl and allenyl gaba
IL100360A (en) * 1990-12-17 1998-08-16 Merrell Dow Pharma HISTORY OF PYROLIDINONE USED AS SUBSTANCE (S) -Vinyl and Alanyl GABA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960927A (en) * 1975-03-18 1976-06-01 Richardson-Merrell Inc. Olefinic derivatives of amino acids
US4178463A (en) * 1978-01-30 1979-12-11 Merrell Toraude Et Compagnie Process for making 4-aminohex-5-enoic acid
GB2120244B (en) * 1982-05-17 1985-05-01 Merrell Toraude & Co Aminoalkadiene derivative

Also Published As

Publication number Publication date
JPS6036448A (ja) 1985-02-25
DK335784A (da) 1985-01-08
ES534115A0 (es) 1986-04-01
DK335784D0 (da) 1984-07-06
HUT34435A (en) 1985-03-28
AU566709B2 (en) 1987-10-29
FI842723A0 (fi) 1984-07-06
ATE31407T1 (de) 1988-01-15
CA1252477A (en) 1989-04-11
ES8603169A1 (es) 1986-01-01
ES8605468A1 (es) 1986-04-01
NO842759L (no) 1985-01-08
AU3037584A (en) 1985-01-10
DE3468103D1 (de) 1988-01-28
ZA845237B (en) 1986-02-26
EP0134481A1 (en) 1985-03-20
EP0134481B1 (en) 1987-12-16
HU198902B (en) 1989-12-28
ES545264A0 (es) 1986-01-01
FI842723A (fi) 1985-01-08
NZ208805A (en) 1989-01-27

Similar Documents

Publication Publication Date Title
KR830007597A (ko) 3-아릴-5-이소티아졸 유도체의 제조방법
KR880012526A (ko) l-페닐-3-나프탈레닐옥시프로판아민
GB9711093D0 (en) Novel orally active iron (III) chelators
WO1999020639A3 (en) NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES
KR860000243A (ko) 아민유도체의 제조방법
KR930016436A (ko) 4, 13-디옥사바이사이클로[8.2.1]트리데세논유도체와 그의 제조방법, 그의 제조를 위한 중간체 및 이화합물이 함유된 약학조성물
KR840003646A (ko) 20-아미노틸로신 유도체의 제조방법
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR890014435A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
KR830006287A (ko) 아데닌 뉴클레오시드 유도체의 제조방법
EA199800155A1 (ru) Новое соединение
KR840003615A (ko) 피리딘 화합물의 제조방법
KR850001151A (ko) r-알레닐-r-아미노부티르산의 제조방법
KR870003107A (ko) 키산틴 유도체의 제조방법
KR880701233A (ko) 새로운 비페닐 유도체와 그의 제조 방법 및 용도
KR900016178A (ko) 2-치환 n,n'-디트리메톡시벤조일 피페라진, 그의 제조 방법 및 그를 함유하는 치료 조성물
KR900000378A (ko) 타이로신유도체 및 그 제조법
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
ES8104241A1 (es) Un procedimiento para la preparacion de compuestos derivadosde 1-((naftil substituido)etil)imidazol
KR920002594A (ko) 5-이소티아졸아민 유도체
KR930007880A (ko) 비스(페닐)에탄 유도체
KR870004038A (ko) 제초제 화합물의 제조방법
KR920700210A (ko) 신규 이미다졸 유도체, 그의 제법 및 그의 의약용도
KR840005713A (ko) [3.2.0]비시클로헵탄온 옥심 에테르류의 제조방법
KR920000371A (ko) 분체의 고결 방지방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application